Ispecimen Inc Quick Ratio (ISPC) starting from the second quarter 2026 to second quarter 2025, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Ispecimen inc   (NASDAQ: ISPC)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare

Ispecimen Inc 's Quick Ratio

ISPC's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Ispecimen Inc 's Cash & cash equivalent grew by 36482.35 % in the Q2 2026 sequentially, faster than Current Liabilities, this led to improvement in Ispecimen Inc 's Quick Ratio to 0.43, Quick Ratio remained below Ispecimen inc average.

Within Medical Laboratories industry 23 other companies have achieved higher Quick Ratio than Ispecimen Inc in second quarter 2026. While Quick Ratio total ranking in the second quarter 2026 has deteriorated compared to the prior quarter from 0 to 2567.

Explain Quick Ratio?
How much Cash & cash equivalents ISPC´s has?
What are ISPC´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ISPC Quick Ratio (Jun 30 2026)
Q2		 (Mar 31 2026)
Q1		 (Dec 31 2025)
Q4		 (Sep 30 2025)
Q3		 (Jun 30 2025)
Q2
Y / Y Current Liabilities Change 97.16 % 13.82 % 7.97 % -9.09 % -10.58 %
Y / Y Cash & cash equivalent Change 36482.35 % 0 % 264.61 % -99.32 % -99.44 %
Quick Ratio MRQ 0.43 0 1.11 0 0
ISPC's Total Ranking # 2567 # 0 # 1755 # 3710 # 3895
Seq. Current Liabilities Change 82.08 % -10.14 % 9.35 % 10.18 % 5.12 %
Seq. Cash & cash equivalent Change 36482.35 % -99.82 % 56866.4 % 0 % 0 %



Quick Ratio second quarter 2026 Company Ranking
Within: No.
Medical Laboratories Industry # 24
Healthcare Sector # 746
Overall Market # 2567


Quick Ratio Statistics
High Average Low
12.76 2.95 0
(Mar 31 2022)   (Sep 30 2025)




Financial Statements
Ispecimen Inc 's Current Liabilities $ 10 Millions Visit ISPC's Balance sheet
Ispecimen Inc 's Cash & cash equivalent $ 4 Millions Visit ISPC's Balance sheet
Source of ISPC's Sales Visit ISPC's Sales by Geography


Cumulative Ispecimen Inc 's Quick Ratio

ISPC's Quick Ratio for the trailling 12 Months

ISPC Quick Ratio

 (Jun 30 2026)
12 Months		 (Mar 31 2026)
12 Months		 (Dec 31 2025)
12 Months		 (Sep 30 2025)
12 Months		 (Jun 30 2025)
12 Months
Y / Y Current Liabilities TTM Growth 25.28 % -0.18 % -5.76 % -8.81 % 5.92 %
Y / Y Cash & cash equivalent TTM Growth 206.07 % 17.98 % -17.95 % -83.37 % -76.02 %
Quick Ratio TTM 0.41 0.31 0.31 0.09 0.17
Total Ranking TTM # 4074 # 0 # 3150 # 3008 # 3180
Seq. Current Liabilities TTM Growth 22.13 % 3.09 % 2.13 % -2.58 % -2.69 %
Seq. Cash & cash equivalent TTM Growth 63.71 % 0 % 259.62 % -48.01 % -36.89 %

Quick ratio ranking by company, industry and sector >> Back to ISPC Financial Strength Comparisons >> Go to Compare ISPC Quick Ratio to its Competitors

On the trailing twelve months basis ISPC Cash & cash equivalent more than doubled by 36482.35 % in Q2 2026 year on year, faster than Current Liabilities, this led to increase in in Ispecimen Inc 's Quick Ratio to 0.41, Quick Ratio remained below ISPC average.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Laboratories industry 38 other companies have achieved higher Quick Ratio than Ispecimen Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the first quarter 2026 from 0 to 4074.

Explain Quick Ratio?
How much Cash & cash equivalents ISPC´s has?
What are ISPC´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Laboratories Industry # 39
Healthcare Sector # 903
Within the Market # 4074


trailing twelve months Quick Ratio Statistics
High Average Low
10.44 3.13 0.09
(Sep 30 2022)   (Sep 30 2025)




Companies with similar Quick Ratio in the quarter ending Jun 30 2026, within Medical Laboratories Industry Quick RatioJun 30 2026 MRQ Cash & cash equivalentJun 30 2026 MRQ Current Liabilities
Radnet Inc   1.11 $ 773.510  Millions$ 697.822  Millions
Bioaffinity Technologies Inc   0.91 $ 2.430  Millions$ 2.681  Millions
Ispecimen inc   0.43 $ 4.426  Millions$ 10.196  Millions
Quest Diagnostics Inc  0.40 $ 720.000  Millions$ 1,788.000  Millions
Lumexa Imaging Holdings Inc   0.39 $ 69.705  Millions$ 178.355  Millions
Medpace Holdings Inc   0.35 $ 502.688  Millions$ 1,435.429  Millions
American Shared Hospital Services  0.30 $ 6.761  Millions$ 22.424  Millions
Nuo Therapeutics, Inc.  0.29 $ 0.449  Millions$ 1.554  Millions
Icon Plc  0.24 $ 930.885  Millions$ 3,934.665  Millions
Fortrea Holdings Inc   0.17 $ 168.600  Millions$ 963.700  Millions
Charles River Laboratories International inc   0.17 $ 192.025  Millions$ 1,134.746  Millions
Nrc Health  0.10 $ 3.327  Millions$ 35.019  Millions

Date modified: 2026-09-26T07:40:00+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.